Results of a safety and immunogenicity study of an early-stage investigational rPA102 vaccine as compared to the FDA licensed anthrax vaccine (anthrax vaccine adsorbed (AVA. BioThrax)).
Hannesschlager
Jennifer R
JR
D022122:Anthrax Vaccines / Q000009:adverse effects* / Q000276:immunology*; D000942:Antigens, Bacterial / Q000276:immunology*; D001427:Bacterial Toxins / Q000276:immunology*; D006801:Humans; D008004:Licensure; D014481:United States; D014486:United States Food and Drug Administration; D014614:Vaccines, Synthetic / Q000009:adverse effects* / Q000276:immunology*
D022122:Anthrax Vaccines; D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D014614:Vaccines, Synthetic; C030325:anthrax toxin